Memorial Şişli Hospital
Ocrevus (ocrelizumab) in Turkey typically costs from AUD $14,506 to AUD $21,759. Final pricing depends on the required dosage, clinic tier, and chosen city, with Istanbul and Ankara being the primary hubs. Patients from Australia save approximately 22% compared to local private costs, where the average price is AUD $18,713. Most Turkish packages include the medication, infusion monitoring, and initial neurologist consultations.
Bookimed Expert Insight: Australian patients find significant value at JCI-accredited facilities like Anadolu Medical Center. Its affiliation with Johns Hopkins Medicine provides reassurance of high clinical standards. Clinics such as Valued Med Hub and VM Medical Park Florya regularly treat Australians, providing familiar English-speaking support. Choosing university-affiliated hospitals often grants access to multidisciplinary teams, including neurology specialists like Dr. Baris Topcular, without the long waitlists common in Australia.
| Turkey | Thailand | South Korea | |
| Ocrevus (ocrelizumab) | from AUD $14,506 | from AUD $29,012 | from AUD $26,401 |
Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.
Professor Topcular completed specialist neurology training at the University of Basel in Switzerland, a global hub for multiple sclerosis research. He now leads neurological care at Istanbul Florence Nightingale Hospital.
The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.
With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.
The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.
Dr Ela Simay Zengin is a neurology specialist at Medicalpoint International Hospital with international credentials from the American Academy of Neurology.